Abstract
Cadmium is a hazardous heavy metal existing ubiquitously in the environment, but the mechanism of cadmium transport into mammalian cells has been poorly understood. Recently, we have established a cadmium-resistant cell line (Cd-rB5) from immortalized metallothionein-null mouse cells, and found that Cd-rB5 cells exhibited a marked decrease in cadmium uptake. To investigate the mechanism of altered uptake of cadmium in Cd-rB5 cells, incorporation of various metals was determined simultaneously using a multitracer technique. Cd-rB5 cells exhibited a marked decrease in manganese incorporation as well as that of cadmium. However, the reduced uptake of manganese was observed only at low concentrations, suggesting that a high-affinity component of the Mn2+ transport system was suppressed in Cd-rB5 cells. Competition experiments and kinetic analyses revealed that low concentrations of Cd2+ and Mn2+ share the same high-affinity pathway for their entry into cells. The mutual competition of Cd2+ and Mn2+ uptake was also observed in HeLa, PC12, and Caco-2 cells. The highest uptake of Cd2+ and Mn2+ by parental cells occurred at neutral pH, suggesting that this pathway is different from a divalent metal transporter 1 that can transport various divalent metals including Cd2+ and Mn2+ under acidic conditions. These results suggest that a high-affinity Mn2+transport system is used for mammalian cellular cadmium uptake, and that the suppression of this pathway caused a marked decrease in cadmium accumulation in cadmium-resistant metallothionein-null cells.
Footnotes
-
Send reprint requests to: Seiichiro Himeno, Ph.D., Kitasato University, School of Pharmaceutical Sciences, Department of Public Health and Molecular Toxicology, 5-9-1, Shirokane, Minato-ku, Tokyo 108-8641 Japan. E-mail:himenos{at}pharm.kitasato-u.ac.jp
- Abbreviations:
- DMT1
- divalent metal transporter 1
- MT
- metallothionein
- DMEM
- Dulbecco's modified Eagle's medium
- Received October 4, 1999.
- Accepted November 22, 1999.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|